GuruFocus.com -- Stock Picks and  Market Insight of Warren Buffett Gurus



Search Articles by Stock Symbol, Guru Names, or Keywords:
All News and Columns »»

Weekly CEO Buy Highlights: Information Services Group Inc, Prospect Capital Corp, CVS Caremark Corp, PharMerica Corp, PHH Corp.

Decrease Font Size Increase Font Size   Print  Print

Nov. 21, 2009 | Filed Under: III , PSEC , CVS , PMC , PHH


Author:

guruyt
1 following



More about III:

Insider Trades



Last week's top five stocks that were bought by their CEOs were Information Services Group Inc, Prospect Capital Corp, CVS Caremark Corp, PharMerica Corp, and PHH Corp. According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Information Services Group Inc (III): Chairman and CEO, 10% Owner Michael P Connors Bought 315,457 Shares

Chairman and CEO, 10% Owner of Information Services Group Inc (III) Michael P Connors bought 315,457 shares on 11/12/2009 at an average price of $3.35. Information Services Group Inc has a market cap of $105.5 million; its shares were traded at around $3.35 with a P/E ratio of 11.6 and P/S ratio of 0.6.

Buy:: Executive VP and CFO David E. Berger bought 125,000 shares of III stock on 11/12/2009 at the average price of 3.17, the price of the stock has increased by 5.68% since. Some other insiders have decreased their positions in the company.

Prospect Capital Corp. (PSEC): CEO John F Barry Bought 87,536 Shares

CEO of Prospect Capital Corp. (PSEC) John F Barry bought 87,536 shares during the past week at an average price of $10.75. Prospect Capital Corp. has a market cap of $557.6 million; its shares were traded at around $10.75 with a P/E ratio of 10.8 and P/S ratio of 5.6. The dividend yield of Prospect Capital Corp. stocks is 15.2%.

Prospect Capital Corp recently reported its third quarter results. The company announced that net investment income was $12.3 million, or 25 cents per weighted average number of shares for the quarter.

Buy:: COO M Grier Eliasek bought 9,500 shares of PSEC stock on 11/18/2009 at the average price of 10.7, the price of the stock has increased by 0.47% since. Many other insiders have also increased their positions in the company.

CVS Caremark Corp. (CVS): CEO & President Thomas M Ryan Bought 17,000 Shares

CEO & President of CVS Caremark Corp. (CVS) Thomas M Ryan bought 17,000 shares on 11/12/2009 at an average price of $31.64. Cvs Caremark Corp. has a market cap of $45.66 billion; its shares were traded at around $31.64 with a P/E ratio of 12.4 and P/S ratio of 0.5. The dividend yield of Cvs Caremark Corp. stocks is 1%. Cvs Caremark Corp. had an annual average earning growth of 10.5% over the past 10 years. GuruFocus rated Cvs Caremark Corp. the business predictability rank of 4-star.

CVS recently reported record third quarter results. The company announced that its Net revenues for the third quarter of 2009, increased $3.8 billion to $24.6 billion, up from $20.9 billion during the third quarter of 2008. Net revenues were positively impacted by one more reporting day during the third quarter of 2009 compared to the third quarter of 2008.

Lee Ainslie bought 5,081,838 shares in the quarter that ended on 09/30/2009, which is 2.18% of the $8.32 billion portfolio of Maverick Capital. George Soros bought 19,000 shares in the quarter that ended on 09/30/2009, which is 0.02% of the $4.41 billion portfolio of Soros Fund Management LLC. Ken Heebner owns 1,597,300 shares as of 09/30/2009, a decrease of 27.1% of from the previous quarter. This position accounts for 0.85% of the $6.72 billion portfolio of CAPITAL GROWTH MANAGEMENT LP.

Sell:: CFO David B Rickard sold 251,520 shares of CVS stock on 08/17/2009 at the average price of 33.96, the price of the stock has decreased by 6.83% since.

PharMerica Corp. (PMC): CEO Gregory S Weishar Bought 25,000 Shares

CEO of PharMerica Corp. (PMC) Gregory S Weishar bought 25,000 shares on 11/13/2009 at an average price of $15.22. Pharmerica Corp. has a market cap of $464.8 million; its shares were traded at around $15.22 with a P/E ratio of 12.3 and P/S ratio of 0.2.

PharMerica recently reported its third quarter results. Net income for the third quarter of 2009 increased to $14.6 million from $4.3 million in the third quarter of 2008, and net income for the nine months ended September 30, 2009, increased to $32.0 million from $10.5 million in the nine months ended September 30, 2008. Excluding a $4.5 million favorable tax adjustment, or $0.15 diluted effect on earnings per share, net income increased 134.9% and 161.9% for the three months and nine months ended September 30, 2009, respectively, over the comparable prior year periods.

John Keeley owns 2,561,700 shares as of 09/30/2009, which accounts for 0.72% of the $6.65 billion portfolio of Keeley Fund Management.

Sell:: SVP and CAO Berard Tomassetti sold 110 shares of PMC stock on 08/11/2009 at the average price of 21.21, the price of the stock has decreased by 28.24% since

PHH Corp. (PHH): President and CEO Jerome J. Selitto Bought 17,500 Shares

President and CEO of PHH Corp. (PHH) Jerome J. Selitto bought 17,500 shares on 11/16/2009 at an average price of $13.95. Phh Corp. has a market cap of $760.5 million; its shares were traded at around $13.95 with and P/S ratio of 0.4.

PHH recently reported its third quarter results. Net revenues for the third quarter of 2009 were $507 million compared to Net revenues of $533 million for the third quarter of 2008. Jerry Selitto, PHH’s new president and chief executive officer, stated, “PHH delivered solid operating performance across our mortgage and fleet businesses during the third quarter, though those improved results were more than offset by the valuation adjustments on MSRs. PHH has been making steady progress in recent quarters, including the signing of a major new private-label account with $1.5B in annualized potential origination volume, but we are not satisfied with our financial performance – and we need to move quickly and aggressively to make PHH as competitive as possible for the long term, while staying true to our core, client-focused values.

HOTCHKIS & WILEY owns 2,753,700 shares as of 09/30/2009, an increase of 12.1% from the previous quarter. This position accounts for 0.38% of the $14.26 billion portfolio of HOTCHKIS & WILEY Capital Management LLC. HOTCHKIS & WILEY owns 2,753,700 shares as of 09/30/2009, which accounts for 0.38% of the $14.26 billion portfolio of HOTCHKIS & WILEY Capital Management LLC. Richard Pzena owns 1,277,535 shares as of 09/30/2009, which accounts for 0.24% of the $10.45 billion portfolio of Pzena Investment Management LLC. Daniel Loeb owns 4,480,000 shares as of 09/30/2009, which accounts for 7.13% of the $1.25 billion portfolio of Third Point, LLC. David Tepper owns 418,703 shares as of 06/30/2009, which accounts for 0.47% of the $1.63 billion portfolio of APPALOOSA MANAGEMENT LP. John Keeley owns 1,677,050 shares as of 09/30/2009, which accounts for 0.5% of the $6.65 billion portfolio of Keeley Fund Management. Edward Lampert sold out his holdings in the quarter that ended on 09/30/2009.

Buy:: Director James O Egan bought 7,000 shares of PHH stock on 11/17/2009 at the average price of 14.13, the price of the stock has decreased by 1.27% since. Sell:: SVP, GC and Secretary William F Brown sold 10,000 shares of PHH stock on 08/14/2009 at the average price of 21, the price of the stock has decreased by 33.57% since.

For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.




Become a Premium Member to See This: (Free Trial):

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

>> Take a Free Trial of Premium Membership


Rate This Article:

Rating: 0.0/5 (0 votes)

   Share This: Facebook  Print

Click to see which Gurus bought III , PSEC , CVS , PMC , PHH ?

Please Leave Your Comment:


More Articles by guruyt:

More Articles about III:


If you like this page, you will love Our Premium Membership, Take a Free Trial.



Tell your friends about This Page:

Your friends' emails: (Comma separated)
Your email address:
Message :


Latest Comments

» stockdocx99: Re: A Coca Cola buy/write combo cou...
» Proselenes: Re: West China Cement ( LSE:WCC ) -...
» batbeer2: Re: Investment Technology Group �...
» superguru: Re: ERTS
» pidu87: Re: Snow Capital Buys Nucor Corp.,....
» Sivaram: Re: Dennis Gartman: Don't Be
» bearuo: Re: NGA - please help
» Dizzy: Re: Bruce Berkowitz bought some Cit...
» Gangstarr: Re: What's The Story With OID?
» kfh227: Re: George Risk Industries: A Pote....
» yswolinsky: Re: GuruFocus Featured in Barron's
» LwC: Re: Sovereign Risk and the Price o....
» kfh227: Re: Munger's Investment Evaluation....
» dbates: Re: Vectren Corp: Our Most Underva....
» girijeeva: Re: Warren Buffett Disciples Using....

Contributing Authors

Home Advertise Site Map Term of Use Privacy Policy Subscribe FAQ Contact Us
© 2004-2010 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC.

Daily updates provided by QuoteMedia, Inc. (CSI). Fundamental company data provided by Zacks, Inc.